Golub Danielle, McBriar Joshua D, Mehta Shyle H, Shah Harshal A, Turpin Justin, White Timothy G, Quach Eric T, Koo Andrew B, Ferreira Christian, Küffer Alexander F, Link Thomas W, Patsalides Athos, Langer David J, Dehdashti Amir R
1Department of Neurosurgery, North Shore University Hospital, Northwell Health, Manhasset, New York.
2Zucker School of Medicine at Hofstra University/Northwell Health, Hempstead, New York.
J Neurosurg. 2024 Dec 6;142(5):1406-1418. doi: 10.3171/2024.7.JNS24321. Print 2025 May 1.
Although well-established in moyamoya disease (MMD), the role of direct superficial temporal artery (STA) to middle cerebral artery (MCA) bypass in non-MMD (N-MMD) cerebrovascular steno-occlusive syndromes remains controversial. Nonetheless, the recurrent stroke risk in patients with N-MMD, despite best medical management, remains exceedingly high-especially for those suffering from hypoperfusion-related ischemia. The study objective was to determine the relative safety and efficacy profiles of direct STA-MCA bypass surgery for MMD and N-MMD patients in a large contemporary cohort.
The authors conducted a retrospective review of all direct STA-MCA bypass cases performed between 2014 and 2023 at a high-volume center, which yielded 139 cases. Cases were excluded if they involved double-barrel bypass, an interposition graft, or if the surgical indication was not cerebral hypoperfusion. Direct bypass graft patency was serially assessed on follow-up vessel imaging.
Of the 139 included cases, 88 (63.3%) were MMD and 51 (36.7%) were N-MMD cases. The mean patient age was 49.2 years and 60.4% were female. The mean follow-up duration was 18.5 months. The perioperative stroke risk within 30 days of revascularization was 6.5% for the overall cohort, with no significant difference (p = 0.725) observed between MMD (5.7%) and N-MMD (7.8%) cases. The overall postoperative ipsilateral hemispheric and MCA distribution stroke rates at last follow-up were 11.5% and 9.4%, respectively. Despite a greater medical comorbidity burden, N-MMD cases demonstrated comparable rates of direct bypass graft occlusion (21.6% N-MMD vs 28.4% MMD, p = 0.426), MCA-distribution ischemic stroke (11.8% N-MMD vs 7.9% MMD, p = 0.549), and ipsilateral ischemic stroke (15.7% N-MMD vs 9.1% MMD, p = 0.276) to patients with MMD at last follow-up. Higher preoperative total hemispheric flow on noninvasive optimal vessel analysis (NOVA) imaging was the only variable associated with prolonged direct bypass graft patency (hazard ratio [HR] 0.39, p = 0.036). Postoperative stroke-free survival was improved by performing dural synangiosis (HR 0.31, p = 0.033) and, in multivariate analysis, was reduced with direct bypass graft occlusion (HR 4.58, p = 0.009) and a preoperative diffusion-weighted imaging-Alberta Stroke Program Early CT Score (DWI-ASPECTS) < 8 (HR 3.90, p = 0.024).
This robust cohort of MMD and N-MMD STA-MCA bypass cases highlights the safety and efficacy of a technically sound direct bypass across all subtypes of cerebrovascular steno-occlusive disease. Careful attention to preoperative MRI parameters, including hemispheric flow rates on NOVA imaging, may improve surgical risk stratification. Further examination of the benefits of adjunctive indirect bypass or dural synangiosis, especially for patients with N-MMD, remains warranted.
虽然颞浅动脉(STA)直接与大脑中动脉(MCA)搭桥术在烟雾病(MMD)中的应用已得到充分确立,但在非烟雾病(N-MMD)脑血管狭窄闭塞综合征中的作用仍存在争议。尽管如此,N-MMD患者即使接受了最佳药物治疗,复发性卒中风险仍然极高,尤其是对于那些患有灌注不足相关缺血的患者。本研究的目的是在一个大型当代队列中确定STA-MCA直接搭桥手术对MMD和N-MMD患者的相对安全性和疗效。
作者对2014年至2023年在一个高容量中心进行的所有STA-MCA直接搭桥病例进行了回顾性分析,共获得139例病例。如果病例涉及双管搭桥、间置移植或手术指征不是脑灌注不足,则将其排除。在随访血管成像中对直接搭桥移植物的通畅情况进行连续评估。
在纳入的139例病例中,88例(63.3%)为MMD,51例(36.7%)为N-MMD病例。患者平均年龄为49.2岁,女性占60.4%。平均随访时间为18.5个月。血管重建术后30天内的围手术期卒中风险在整个队列中为6.5%,MMD(5.7%)和N-MMD(7.8%)病例之间未观察到显著差异(p = 0.725)。最后一次随访时,总体术后同侧半球和MCA分布区的卒中发生率分别为11.5%和9.4%。尽管N-MMD病例的合并症负担更重,但在最后一次随访时,N-MMD病例的直接搭桥移植物闭塞率(N-MMD为21.6%,MMD为28.4%,p = 0.426)、MCA分布区缺血性卒中发生率(N-MMD为11.8%,MMD为7.9%,p = 0.549)和同侧缺血性卒中发生率(N-MMD为15.7%,MMD为9.1%,p = 0.276)与MMD患者相当。术前无创最佳血管分析(NOVA)成像显示的较高全半球血流是与直接搭桥移植物通畅时间延长相关的唯一变量(风险比[HR] 0.39,p = 0.036)。进行硬脑膜血管吻合术可改善术后无卒中生存期(HR 0.31,p = 0.033),在多变量分析中,直接搭桥移植物闭塞(HR 4.58,p = 0.009)和术前弥散加权成像-阿尔伯塔卒中项目早期CT评分(DWI-ASPECTS)< 8(HR 3.90,p = 0.024)会降低术后无卒中生存期。
这个包含MMD和N-MMD患者的STA-MCA搭桥病例的强大队列突出了在所有脑血管狭窄闭塞性疾病亚型中进行技术上可靠的直接搭桥的安全性和疗效。仔细关注术前MRI参数,包括NOVA成像上的半球血流速度,可能会改善手术风险分层。对于辅助性间接搭桥或硬脑膜血管吻合术的益处,尤其是对N-MMD患者,仍有必要进一步研究。